Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?

被引：11
|
作者：
Varghese, Ryan [1 ,2 ]
Kumar, Dileep [1 ,3 ,4 ]
Sharma, Rohit [5 ]
机构：
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Pune 411038, Maharashtra, India
[2] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Dept Clin Pharmacol, Kharghar 410210, Navi Mumbai, India
[3] Univ Calif Davis, Dept Entomol, One Shields Ave, Davis, CA 95616 USA
[4] Univ Calif Davis, UC Davis Comprehens Canc Ctr, One Shields Ave, Davis, CA 95616 USA
[5] Banaras Hindu Univ, Inst Med Sci, Fac Ayurveda, Dept Rasa Shastra & Bhaishajya Kalpana, Varanasi 221005, Uttar Pradesh, India
来源：
HUMAN CELL | 2023年 / 36卷 / 03期
关键词：
SARS-CoV-2; COVID-19; Variants; BF.7; BQ.1; BQ.1.1; XBB.1.5;
D O I：
10.1007/s13577-023-00903-9
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1218 / 1221
页数：4
相关论文
共 32 条
  • [21] A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants
    Guselnikov, Sergey V.
    Baranov, Konstantin O.
    Kulemzin, Sergey V.
    Belovezhets, Tatyana N.
    Chikaev, Anton N.
    Murasheva, Svetlana V.
    Volkova, Olga Y.
    Mechetina, Ludmila V.
    Najakshin, Alexander M.
    Chikaev, Nikolai A.
    Solodkov, Pavel P.
    Sergeeva, Maria V.
    Smirnov, Alexander V.
    Serova, Irina A.
    Serov, Oleg L.
    Markhaev, Alexander G.
    Kononova, Yulia V.
    Alekseev, Alexander Y.
    Gulyaeva, Marina A.
    Danilenko, Daria M.
    Battulin, Nariman R.
    Shestopalov, Alexander M.
    Taranin, Alexander V.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Susceptibility of bovine to SARS-CoV-2 variants of concern: insights from ACE2, AXL, and NRP1 receptors
    Ma, Ying
    Lei, Mengyue
    Chen, Hongli
    Huang, Pu
    Sun, Jing
    Sun, Qiangming
    Hu, Yunzhang
    Shi, Jiandong
    VIROLOGY JOURNAL, 2023, 20 (01)
  • [23] Growth, reproduction numbers and factors affecting the spread of SARS-CoV-2 novel variants of concern in the UK from October 2020 to July 2021: a modelling analysis
    Ward, Thomas
    Glaser, Alex
    Johnsen, Alexander
    Xu, Feng
    Hall, Ian
    Pellis, Lorenzo
    BMJ OPEN, 2021, 11 (11):
  • [24] Emerging SARS-CoV-2 variants of concern potentially expand host range to chickens: insights from AXL, NRP1 and ACE2 receptors
    Lei, Mengyue
    Ma, Ying
    Chen, Hongli
    Huang, Pu
    Sun, Jing
    Wang, Xu
    Sun, Qiangming
    Hu, Yunzhang
    Shi, Jiandong
    VIROLOGY JOURNAL, 2023, 20 (01)
  • [25] Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh
    Al-Emran, Hassan M.
    Hasan, Md. Shazid
    Setu, Md. AliAhasan
    Rahman, M. Shaminur
    Ul Alam, A. S. M. Rubayet
    Sarkar, Shovon Lal
    Islam, Md. Tanvir
    Islam, Mir Raihanul
    Rahman, Mohammad Mahfuzu
    Islam, Ovinu Kibria
    Jahid, Iqbal Kabir
    Hossain, M. Anwar
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (02) : 156 - 163
  • [26] XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease
    Woelfel, Simon
    Duetschler, Joel
    Junker, Daniel
    Koenig, Marius
    Graf, Nicole
    Krieger, Claudia
    Truniger, Samuel
    Oikonomou, Vasileios
    Leinenkugel, Georg
    Koller, Seraina
    Metzger-Peter, Katline
    Wyss, Jacqueline
    Krupka, Niklas
    Frei, Nicola
    Albrich, Werner C.
    Friedrich, Matthias
    Niess, Jan Hendrik
    Schneiderhan-Marra, Nicole
    Dulovic, Alex
    Misselwitz, Benjamin
    Korte, Wolfgang
    Buergi, Justus J.
    Brand, Stephan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 299 - 312
  • [27] The application of a novel 5-in-1 multiplex reverse transcriptase-polymerase chain reaction assay for rapid detection of SARS-CoV-2 and differentiation between variants of concern
    Chung, Hsing-Yi
    Jian, Ming
    Chang, Chih-Kai
    Chen, Chi-Sheng
    Li, Shih-Yi
    Yeh, Kuo-Ming
    Yang, Ya-Sung
    Tang, Sheng-Hui
    Chen, Chien-Wen
    Perng, Cherng-Lih
    Hung, Kuo-Sheng
    Chang, Feng-Yee
    Shang, Hung-Sheng
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 127 : 56 - 62
  • [28] Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern
    Zhang, Ru-Yan
    Zhou, Shi-Hao
    He, Chen-Bin
    Wang, Jian
    Wen, Yu
    Feng, Ran-Ran
    Yin, Xu-Guang
    Yang, Guang-Fu
    Guo, Jun
    ACS INFECTIOUS DISEASES, 2022, 8 (07): : 1367 - 1375
  • [29] The wind of change: Gibbs energy of binding and infectivity evolution of Omicron BA.2.86 Pirola, EG.5.1, XBB.1.16 Arcturus, CH.1.1 and BN.1 variants of SARS-CoV-2
    Popovic, Marko E.
    Sekularac, Gavrilo
    Popovic, Marta
    MICROBIAL RISK ANALYSIS, 2024, 26
  • [30] Immunogenicity of novel DNA vaccines encoding receptor-binding domain (RBD) dimer-Fc fusing antigens derived from different SARS-CoV-2 variants of concern
    Zhang, Ting
    Wang, Zhirong
    Yang, Jiaojiao
    Xu, Xuemei
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
1234